On March 1, 2023, Inclusive Capital, which took a stake in Bayer earlier this year, are trying to force management to break up the company, which claiming one victory: the appointment of an outside candidate, Bill Anderson, to replace former CEO Werner Baumann, intends to split the Company into at least two parts: agribusiness and healthcare.